PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases Division, Santé publique France, Saint-Maurice, France. stephane.levu@gmail.com.\', \'Infectious Diseases Division, Santé publique France, Saint-Maurice, France.\', \'Unit of Molecular Virology and Vaccinology, Virology Department, Theravectys, Institut Pasteur, Paris, France.\', \'Unit of Lymphocyte Cell Biology, Immunology Department, INSERM 1221, Institut Pasteur, Paris, France.\', \'Data Sciences Division, Santé publique France, Saint-Maurice, France.\', \'Unit of Molecular Genetics of RNA Viruses, UMR 3569 CNRS, University of Paris-Diderot, Institut Pasteur, Paris, France.\', \'Unit of Chemistry and Biocatalysis, UMR 3523 CNRS, Institut Pasteur, Paris, France.\', \'Innovation Laboratory: Vaccines, Institut Pasteur, Paris, France.\', \'Production and Purification of Recombinant Proteins Technological Platform, Institut Pasteur, Paris, France.\', \'Cerba Healthcare Division, Cerba Xpert, St Ouen L\'Aumone, France.\', \'Eurofins Biomnis Sample Library, Eurofins Biomnis, Lyon, France.\', \'ICAReB Biobanking Platform, Center for Translational Science, Institut Pasteur, Paris, France.\', \'Regional Office-French Caribbean, Santé publique France, Gourbeyre, France.\', \'Regional Office-Brittany, Santé publique France, Rennes, France.\', \'Regional Office-Nouvelle Aquitaine, Santé publique France, Bordeaux, France.\', \'National Reference Center for Respiratory Infections Viruses Including Influenza, Institut Pasteur, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-23233-6
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34021152
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
?:title
  • Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all